BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 1289914)

  • 21. The clinical utility of visual evaluation of scintigraphic perfusion patterns for Alzheimer's disease using I-123 IMP SPECT.
    Ishii K; Mori E; Kitagaki H; Sakamoto S; Yamaji S; Imamura T; Ikejiri Y; Kono M
    Clin Nucl Med; 1996 Feb; 21(2):106-10. PubMed ID: 8697677
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Differential diagnosis of bilateral parietal abnormalities in I-123 IMP SPECT imaging.
    Kuwabara Y; Ichiya Y; Otsuka M; Tahara T; Fukumura T; Gunasekera R; Masuda K
    Clin Nucl Med; 1990 Dec; 15(12):893-9. PubMed ID: 2276232
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Mapping cerebral blood flow.
    Ell PJ
    J Nucl Med; 1992 Oct; 33(10):1843-5. PubMed ID: 1403154
    [No Abstract]   [Full Text] [Related]  

  • 24. Single photon emission computed tomography (SPECT) with [123I]IMP in the differential diagnosis of psychiatric disorders.
    O'Connell RA; Van Heertum RL; Billick SB; Holt AR; Gonzalez A; Notardonato H; Luck D; King LN
    J Neuropsychiatry Clin Neurosci; 1989; 1(2):145-53. PubMed ID: 2521055
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Single photon emission tomography with 123I-isopropylamphetamine in Alzheimer's disease and multi-infarct dementia.
    Gemmell HG; Sharp PF; Evans NT; Besson JA; Lyall D; Smith FW
    Lancet; 1984 Dec; 2(8415):1348. PubMed ID: 6150361
    [No Abstract]   [Full Text] [Related]  

  • 26. Quantitative measurement of regional cerebral blood flow using N-isopropyl-(iodine-123)p-iodoamphetamine and single-photon emission computed tomography.
    Takeshita G; Maeda H; Nakane K; Toyama H; Sakakibara E; Komai S; Takeuchi A; Koga S; Ono M; Nakagawa T
    J Nucl Med; 1992 Oct; 33(10):1741-9. PubMed ID: 1403139
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The use and applications of single-photon emission computerised tomography in dementia.
    Geaney DP; Abou-Saleh MT
    Br J Psychiatry Suppl; 1990; (9):66-75. PubMed ID: 2291821
    [No Abstract]   [Full Text] [Related]  

  • 28. Studying regional brain function: a challenge for SPECT.
    Coleman RE; Drayer BP; Jaszczak RJ
    J Nucl Med; 1982 Mar; 23(3):266-70. PubMed ID: 7038057
    [No Abstract]   [Full Text] [Related]  

  • 29. Early and delayed technetium-99m-ECD brain SPECT in stroke.
    Grünwald F; Pavics L; Biersack HJ
    J Nucl Med; 1995 Apr; 36(4):712-3. PubMed ID: 7755764
    [No Abstract]   [Full Text] [Related]  

  • 30. Crossed cerebellar diaschisis: analysis of iodine-123-IMP SPECT imaging.
    Flores LG; Futami S; Hoshi H; Nagamachi S; Ohnishi T; Jinnouchi S; Watanabe K
    J Nucl Med; 1995 Mar; 36(3):399-402. PubMed ID: 7884501
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Diagnosis of dementia and neurodegenerative disorders by brain SPECT of three dimensional stereotactic surface projection method].
    Kageyama H
    Hokkaido Igaku Zasshi; 2004 Mar; 79(2):117-21, 123-7. PubMed ID: 15101187
    [No Abstract]   [Full Text] [Related]  

  • 32. Application of iodine-123-labeled isopropylamphetamine imaging to the study of dementia.
    Sharp P; Gemmell H; Cherryman G; Besson J; Crawford J; Smith F
    J Nucl Med; 1986 Jun; 27(6):761-8. PubMed ID: 3712090
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Three-dimensional surface display with 123I-IMP brain perfusion imaging in patients with dementia].
    Tomino Y; Tachibana H; Sugita M
    Rinsho Shinkeigaku; 1994 Apr; 34(4):318-25. PubMed ID: 8026123
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Single photon emission tomographic brain images in dementia of the Alzheimer type.
    Hendrie HC; Wellman HN; Hall KS; Farlow MR; Brittain HM; Demyer MK
    Am J Psychiatry; 1987 Mar; 144(3):387-8. PubMed ID: 3493708
    [No Abstract]   [Full Text] [Related]  

  • 35. The utility of cerebral blood flow imaging in patients with the unique syndrome of progressive dementia with motor neuron disease.
    Ohnishi T; Hoshi H; Jinnouchi S; Nagamachi S; Watanabe K; Mituyama Y
    J Nucl Med; 1990 May; 31(5):688-91. PubMed ID: 2341906
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [3-dimensional imaging of regional cerebral blood flow by means of emission computed tomography].
    Higano S; Uemura K; Kanno I
    Nihon Rinsho; 1990 Jul; 48(7):1591-8. PubMed ID: 2119464
    [No Abstract]   [Full Text] [Related]  

  • 37. Cerebral perfusion in progressive supranuclear palsy.
    Johnson KA; Sperling RA; Holman BL; Nagel JS; Growdon JH
    J Nucl Med; 1992 May; 33(5):704-9. PubMed ID: 1569479
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Regional dynamics of N-isopropyl-(123I)p-iodoamphetamine in human brain.
    Nishizawa S; Tanada S; Yonekura Y; Fujita T; Mukai T; Saji H; Fukuyama H; Miyoshi T; Harada K; Ishikawa M
    J Nucl Med; 1989 Feb; 30(2):150-6. PubMed ID: 2786930
    [TBL] [Abstract][Full Text] [Related]  

  • 39. In vivo imaging of cerebral muscarinic receptors with I-123 QNB and SPECT: studies in normal subjects and patients with dementia.
    Weinberger DR; Jones DW; Sunderland T; Lee KS; Sexton R; Gorey J; Reba R
    Clin Neuropharmacol; 1992; 15 Suppl 1 Pt A():194A-195A. PubMed ID: 1498808
    [No Abstract]   [Full Text] [Related]  

  • 40. [Clinical cerebral perfusion scintigraphy with 123I-IMP].
    Watanabe K; Hoshi H; Jinnouchi S; Yoshimura H; Nagamachi S
    Rinsho Hoshasen; 1989 Mar; 34(3):303-12. PubMed ID: 2661883
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.